GlassScriptPhysician profile
Sidney S Devins
NPI 1336110659
$11,225.98
in general payments reported to CMS, 2019-2025
48 companies · $3,305 in 2025
The $3,305 reported for 2025 was more than what 84% of Pulmonary Disease providers received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $150 · 2021: $121 · 2022: $2,271 · 2023: $2,741 · 2024: $2,638 · 2025: $3,305.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $8,442 · Education: $242.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $8,441.71 |
| Education | $242.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $2,230.86 | 2021-2025 | Fasenra, Tezspire, Breztri |
| Glaxosmithkline, LLC. | $1,070.53 | 2022-2025 | Nucala, Trelegy Ellipta, Arexvy |
| Genzyme Corporation | $1,056.34 | 2022-2025 | |
| Regeneron Healthcare Solutions, INC. | $1,016.53 | 2020-2025 | Dupixent |
| Jazz Pharmaceuticals INC. | $816.57 | 2020-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $551.26 | 2022-2025 | Stiolto Respimat, Ofev, Spiriva Respimat |
| Harmony Biosciences LLC | $534.24 | 2022-2025 | Wakix |
| Grifols USA, LLC | $502.47 | 2022-2025 | Prolastin-C Liquid |
| Amgen INC. | $422.72 | 2022-2025 | Tezspire, Tavneos |
| Inspire Medical Systems, INC. | $293.39 | 2022 | |
| United Therapeutics Corporation | $286.18 | 2022-2025 | |
| Axsome Therapeutics, INC. | $279.62 | 2023-2025 | Sunosi |
| Novartis Pharmaceuticals Corporation | $211.82 | 2022-2024 | |
| Philips North America LLC | $182.53 | 2024-2025 | Vest Therapy Und, Encore, Patient Interface Software |
| Insmed, INC. | $178.91 | 2022-2025 | Arikayce |
Show all 48 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Verona Pharma, INC. | $178.41 | 2025 | Ohtuvayre |
| Baxter Healthcare | $120.54 | 2022-2025 | Hillrom - Vest System Model 205 Acute Care, Hillrom - Monarch Airway Clearance System, Perclot |
| Genentech USA, INC. | $114.96 | 2022-2025 | Xolair |
| Ge Healthcare | $88.86 | 2023 | |
| Mallinckrodt Hospital Products INC. | $87.94 | 2022-2023 | Acthar |
| Takeda Pharmaceuticals U.S.A., INC. | $85.65 | 2024-2025 | Glassia |
| Karl Storz Endoscopy-America | $71.58 | 2023 | Tele Pack |
| Merck Sharp & Dohme LLC | $68.89 | 2023-2025 | Keytruda |
| Saluda Medical Americas, INC. | $66.26 | 2023 | Evoke Scs |
| Optinose US, INC. | $63.54 | 2022-2024 | |
| Viiv Healthcare Company | $61.64 | 2025 | Dovato |
| Sanofi-Aventis U.S. LLC | $57.48 | 2024 | |
| Stryker Corporation | $50.59 | 2024 | Scopis Ent |
| Avadel Cns Pharmaceuticals, LLC | $42.15 | 2024-2025 | Lumryz |
| Mylan Specialty L.P. | $39.27 | 2022-2023 | Yupelri |
| Xeris Pharmaceuticals, INC. | $38.40 | 2024-2025 | Keveyis, Recorlev |
| Innovation Technologies INC | $37.02 | 2023 | Irrisept |
| Ars Pharmaceuticals Operations, INC. | $36.40 | 2025 | Neffy |
| Zoll Respicardia, INC. | $36.07 | 2023 | Remede System |
| Inogen, INC. | $27.93 | 2023 | Inogen One G5 Oxygen Concentrator - Bluetooth |
| Vertex Pharmaceuticals Incorporated | $23.96 | 2025 | |
| Viatris Specialty LLC | $23.39 | 2025 | Yupelri |
| Sanofi Pasteur INC. | $20.82 | 2023 | |
| Kaleo, INC. | $18.83 | 2023 | Auvi-Q |
| Lilly USA, LLC | $18.32 | 2025 | Zepbound |
| Actelion Pharmaceuticals US, INC. | $16.68 | 2024 | Opsumit, Uptravi |
| Melinta Therapeutics, LLC | $15.88 | 2025 | Orbactiv, Kimyrsa, Rezzayo |
| Electromed, INC. | $14.84 | 2024 | Smartvest |
| Hologic Sales and Service, LLC | $14.40 | 2025 | Coolseal Generator |
| Bayer Healthcare Pharmaceuticals INC. | $14.19 | 2024 | |
| Covis Pharma Gmbh | $13.77 | 2022 | |
| Teva Pharmaceuticals USA, INC. | $12.24 | 2022 | |
| Phathom Pharmaceuticals, INC. | $11.11 | 2025 | Voquezna |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sidney Devins listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.